• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, November 13, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Study: Dangerous parasite controls host cell to spread around body

Bioengineer by Bioengineer
July 16, 2020
in Health
Reading Time: 2 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: IU School of Medicine

Researchers at Indiana University School of Medicine have discovered new information about how a dangerous parasite takes control of a patient’s cells as it spreads throughout their body, an important finding that could help in the development of new drugs to treat this infection.

“The parasite essentially hijacks these cells, using them as vehicles to get to various organ systems, including the brain,” said Leonardo Augusto, PhD, a postdoctoral fellow in the Department of Pharmacology and Toxicology and lead author on the National Institutes of Health-funded study, which was recently published in mBio. “It’s like the parasite is taking the wheel of its host cell and using it to spread around the body.”

Toxoplasma gondii infects up to one-third of the world’s population. People typically become infected with it through exposure to cat feces, which is where it goes through its reproductive phases, or consumption of contaminated food and water. The parasite causes life-threatening issues in some patients because of its ability to disseminate to the brain. In the brain and other tissues, the parasite persists as a latent cyst, waiting to reactivate if immunity should wane, such as what happens in HIV/AIDS patients.

“One of the key problems in battling an infection like Toxoplasma is controlling its spread to other parts of the body,” Augusto said. “Upon ingestion of the parasite, it makes its way into immune cells and causes them to move–a behavior called hypermigratory activity. How these parasites cause their infected cells to start migrating is largely unknown.”

The team’s new research is shedding light on this important clinical question, discovering that the parasite trips an alarm system in its host cell that leads to the activation of a protein called IRE1. IRE1 helps the cell cope with stress, which can involve getting it to move to a different location. In cells infected with Toxoplasma, IRE1 connects to the cytoskeleton, a network of structural proteins that gives the cell its shape and coordinates movement. By engaging this network through IRE1, Toxoplasma takes the wheel and causes hypermigration.

“When we infected host cells that were depleted of IRE1, they could no longer move,” Augusto said. “These cells were greatly impaired at disseminating Toxoplasma to the brains of infected mice.”

These findings reveal a new mechanism underlying host-pathogen interactions, demonstrating how host cells are co-opted to spread a persistent infection. A better understanding of this pathogen dissemination is helpful in the development of new drugs to curtail the spread of a Toxoplasma gondii infection throughout the body.

###

The work is part of a longstanding collaboration between Bill Sullivan, PhD, Showalter professor in the Department of Pharmacology and Toxicology, and Ronald Wek, PhD, Showalter professor in the Department of Biochemistry and Molecular Biology.

Media Contact
Christina Griffiths
griffchm@iu.edu

Original Source

https://medicine.iu.edu/news/2020/07/toxoplasma-study-published-in-mbio

Related Journal Article

http://dx.doi.org/10.1128/mBio.00915-20

Tags: Cell BiologyMedicine/HealthMicrobiologyMolecular BiologyParasitologyToxicology
Share13Tweet8Share2ShareShareShare2

Related Posts

Stakeholder Alignment, Adaptive Designs, and Dedicated Funding Drive Accelerated Clinical Development

Stakeholder Alignment, Adaptive Designs, and Dedicated Funding Drive Accelerated Clinical Development

November 13, 2026
Pre-Drainage Model Predicts Moderate-to-Severe Acute Cholangitis but Overestimates Risk

Pre-Drainage Model Predicts Moderate-to-Severe Acute Cholangitis but Overestimates Risk

November 13, 2026

Clinical Nomogram Predicts Pulmonary Embolism Risk in Severe Pneumonia ICU Patients

November 13, 2026

Clinical validation and literature review of robot-assisted cerebral angiography

November 13, 2026
Please login to join discussion

POPULAR NEWS

  • Review Links Mitochondrial Dysfunction to Metabolic Liver Disease Progression

    Review Links Mitochondrial Dysfunction to Metabolic Liver Disease Progression

    29 shares
    Share 12 Tweet 7
  • CRISPR Interference Offers Reversible Gene Silencing for Pest Management, Review Reports

    29 shares
    Share 12 Tweet 7
  • Nocardia farcinica Emerged as Leading Species in Drug-Resistant Infection Study

    29 shares
    Share 12 Tweet 7
  • Seawater Elements on Enamel May Aid Drowning Time Estimates

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Stakeholder Alignment, Adaptive Designs, and Dedicated Funding Drive Accelerated Clinical Development

Pre-Drainage Model Predicts Moderate-to-Severe Acute Cholangitis but Overestimates Risk

Mycobacterium abscessus Drug Discovery Reveals Divergent Cellular Pharmacology Across MmpL3 Inhibitors

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 86 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.